Filing Details

Accession Number:
0001214659-20-002746
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-18 16:45:20
Reporting Period:
2020-03-16
Accepted Time:
2020-03-18 16:45:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1398733 Aquestive Therapeutics Inc. AQST Pharmaceutical Preparations (2834) 208623253
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1739816 E. Peter Boyd C/O Aquestive Therapeutics, Inc.
30 Technology Drive
Warren NJ 07059
Svp-Bus. Process & Info. Tech. No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-16 2,000 $1.50 52,239 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2020-03-16 50,700 $0.00 50,700 $1.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
50,700 2030-03-16 No 4 A Direct
Footnotes
  1. The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.